IKNA: Ikena Oncology, Inc. Narx-foyda va o‘sish multiplikatori

Ikena (IKNA) brendining ramzi va logotipi

Ikena Oncology, Inc. (IKNA) genetik o'simta o'sish yo'llarini bloklash uchun aniq terapiyani joriy qilmoqda. Kompaniya RAS va Hippo mutatsiyalariga qarshi maqsadli molekulalarni ishlab chiqmoqda, garchi yuqori R&D xarajatlari rezervlarni kamaytirayotgan bo'lsa-da. GURU.Markets terminal grafigidagi xarajatlarning biznes kengayish sur'atlariga nisbati bozor dinamikasini aks ettiradi, bunda 0.00 darajasi aktivning fundamental baholashining joriy holatini ifodalaydi.

Narxning foydaga va o‘sish sur’atiga nisbati: Ikena Oncology Inc. (IKNA) 04.07.2022 - 09.08.2025 uchun

Ikena (IKNA) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:IKNA Ikena
Ikena Oncology Inc. seriyali mahsuloti

Ikena Oncology, Inc. (IKNA) tomonidan uzoq muddatli patent himoyasiga ega innovatsion onkologik dori vositalarini ishlab chiqilishi biznesning uzoq muddatli istiqbollarini belgilaydi, bu esa PEG koeffitsiyenti dinamikasida yaqqol aks etgan. Ushbu koeffitsient P/E bozor multiplikatorini foyda o'sish sur'atlari bilan solishtiradi, bu esa investorlarga aktivlarning qadrsizlanganini aniqlash imkonini beradi: birdan past qiymat fundamental barqarorlikning yuqoriligini va kompaniyaning kelgusidagi o'sishi uchun ortiqcha to'lov qilinmaganini anglatadi.

Raqobatdosh kompaniyalar

Narx-foyda va o‘sish multiplikatori BeiGene Ltd ONC|PEG multiplikatori HALO (halozyme.com)|RVMD - Narx-foyda va o‘sish multiplikatori|AAPG: Narx-foyda va o‘sish multiplikatori|CGON - PEG multiplikatori|UroGen (URGN) - Narxning foydaga va o‘sish sur’atiga nisbati|Bicara Bio - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PSNL (Personalis Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Erasca, Inc. ERAS|PEG multiplikatori DCTH|YMAB - O‘sish sur’atiga tuzatilgan narx-foyda|Aura Biosciences Inc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Candel Therapeutics CADL|accuray.com - PEG multiplikatori|SLS: Narxning foydaga va o‘sish sur’atiga nisbati|ACTU (actuatetherapeutics.com) - Narx-foyda va o‘sish multiplikatori|CTOR - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati tuhurabio.com|PEG multiplikatori Protara Tx|Narx-foyda va o‘sish multiplikatori FATE (Fate Therapeutics Corp)|Narxning foydaga va o‘sish sur’atiga nisbati WHWK (Aadi Bioscience)|TScan Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Champions Oncology (CSBR) - O‘sish sur’atiga tuzatilgan narx-foyda|XBiotech - PEG multiplikatori|CEL-SCI (CVM) - Narx-foyda va o‘sish multiplikatori|OS Therapies Inc (OSTX) - Narxning foydaga va o‘sish sur’atiga nisbati|radiopharmtheranostics.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Artiva Biotherapeutics Inc.|O‘sish sur’atiga tuzatilgan narx-foyda Adlai Nortye Ltd. ANL|PEG multiplikatori VERU|TPST - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori XLO (Xilio Therapeutics)|RENB - Narx-foyda va o‘sish multiplikatori|muraloncology.com - PEG multiplikatori|KAPA - PEG multiplikatori|OKUR: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati GDTC (CytoMed Therapeutics Ltd)|CRIS (curis.com) - PEG multiplikatori|Apollomics, Inc. (APLM) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori THAR (Tharimmune, Inc.)|ADVB (Advanced Biomed) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori GNPX (Genprex Inc)|calidibio.com (CLDI) - O‘sish sur’atiga tuzatilgan narx-foyda|sunshinebiopharma.com - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Xenetic Biosciences, Inc.|SLRX (Salarius Pharmaceuticals) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori Purple Biotech Ltd.|AONC (American Oncology Network Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori BeOne Medicines (BGNE)|PEG multiplikatori CKPT|ELEV - O‘sish sur’atiga tuzatilgan narx-foyda|iCAD Inc. - Narx-foyda va o‘sish multiplikatori|NTBL - Narx-foyda va o‘sish multiplikatori|VIRX - Narxning foydaga va o‘sish sur’atiga nisbati|MOR - PEG multiplikatori|NAYA: PEG multiplikatori|Ascentage Pharma Group (AAPGV) - PEG multiplikatori